Altered de novo lipogenesis contributes to low adipose stores in cystic fibrosis mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 303, Issue 4, 2012, Pages

  Bederman, Ilya ^a   Perez, Aura ^a   Henderson, Leigh ^a   Freedman, Joshua A ^a   Poleman, James ^a   Guentert, Dana ^a   Ruhrkraut, Nicholas ^a   Drumm, Mitchell L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; F508del

Indexed keywords

PALMITIC ACID; STEARIC ACID; TRANSCRIPTOME; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISORDERS OF LIPID METABOLISM; FATTY ACID SYNTHESIS; FEMALE; FOOD INTAKE; GENE MUTATION; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ADIPOSE TISSUE; ADIPOSITY; AGE FACTORS; AGING; ANIMALS; BODY MASS INDEX; BODY WEIGHT; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; EATING; ENERGY INTAKE; FATTY ACIDS; FECES; FEMALE; GENE EXPRESSION REGULATION; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED CFTR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIGLYCERIDES;

EID: 84865119708     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00451.2011     Document Type: Article

References (53)

1. Ajie HO, Connor MJ, Lee WN, Bassilian S, Bergner EA, Byerley LO. In vivo study of the biosynthesis of long-chain fatty acids using deuterated water. Am J Physiol Endocrinol Metab 269: E247-E252, 1995.
2. Bederman IR, Dufner DA, Alexander JC, Previs SF. Novel application of the "doubly labeled" water method: measuring CO2 production and the tissue-specific dynamics of lipid and protein in vivo. Am J Physiol Endocrinol Metab 290: E1048-E1056, 2006.
3. Bederman IR, Foy S, Chandramouli V, Alexander JC, Previs SF. Triglyceride synthesis in epididymal adipose tissue: contribution of glu cose and non-glucose carbon sources. J Biol Chem 284: 6101-6108, 2009.
4. Berger M. Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? Clin Rev Allergy 9: 119-142, 1991.
5. Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 288: G646-G653, 2005.
6. Bijvelds MJ, Jorna H, Verkade HJ, Bot AG, Hofmann F, Agellon LB, Sinaasappel M, de Jonge HR. Activation of CFTR by ASBT-mediated bile salt absorption. Am J Physiol Gastrointest Liver Physiol 289: G870-G879, 2005.
7. Brunengraber DZ, McCabe BJ, Kasumov T, Alexander JC, Chandramouli V, Previs SF. Influence of diet on the modeling of adipose tissue triglycerides during growth. Am J Physiol Endocrinol Metab 285: E917-E925, 2003.
8. Bu SY, Mashek MT, Mashek DG. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J Biol Chem 284: 30474-30483, 2009.
9. Canale-Zambrano JC, Auger ML, Haston CK. Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 299: G381-G390, 2010.
10. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134: 933-944, 2008.
11. Chakravarthy MV, Zhu Y, Yin L, Coleman T, Pappan KL, Marshall CA, McDaniel ML, Semenkovich CF. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. J Lipid Res 50: 630-640, 2009.
12. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, Boucher RC. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 257: 1125-1128, 1992.
13. Folch J, Lees M, Sloane-Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
14. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 45: 1201-1210, 2002.
15. Girard J, Ferre P, Pegorier JP, Duee PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 72: 507-562, 1992.
16. Grubb BR, Gabriel SE. Intestinal physiology and pathology in genetargeted mouse models of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 273: G258-G266, 1997.
17. Hodges CA, Grady BR, Mishra K, Cotton CU, Drumm ML. Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 301: G528-G536, 2011.
18. Ip WF, Bronsveld I, Kent G, Corey M, Durie PR. Exocrine pancreatic alterations in long-lived surviving cystic fibrosis mice. Pediatr Res 40: 242-249, 1996.
19. 2H2O: advantage of isotope fractionation during gas chromatography. Am J Physiol Endocrinol Metab 284: E1043-E1048, 2003.
20. Knight CH, Maltz E, Docherty AH. Milk yield and composition in mice: effects of litter size and lactation number. Comp Biochem Physiol A Comp Physiol 84: 127-133, 1986.
21. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 142: 624-630, 2003.
22. Landon C, Kerner JA, Castillo R, Adams L, Whalen R, Lewiston NJ. Oral correction of essential fatty acid deficiency in cystic fibrosis. JPEN J Parenter Enteral Nutr 5: 501-504, 1981.
23. Lee WN, Bassilian S, Lim S, Boros LG. Loss of regulation of lipogenesis in the Zucker diabetic (ZDF) rat. Am J Physiol Endocrinol Metab 279: E425-E432, 2000.
24. Letexier D, Pinteur C, Large V, Frering V, Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J Lipid Res 44: 2127-2134, 2003.
25. Littlewood JM, Wolfe SP. Control of malabsorption in cystic fibrosis. Paediatr Drugs 2: 205-222, 2000.
26. Lodhi IJ, Wei X, Semenkovich CF. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol Metab 22: 1-8, 2011.
27. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288: 2379-2381, 2000.
28. Malik RC. Genetic and physiological aspects of growth, body composition and feed efficiency in mice: a review. J Anim Sci 58: 577-590, 1984.
29. Nasr SZ, Drury D. Appetite stimulants use in cystic fibrosis. Pediatr Pulmonol 43: 209-219, 2008.
30. Newby MJ, Keim NL, Brown DL. Body composition of adult cystic fibrosis patients and control subjects as determined by densitometry, bioelectrical impedance, total-body electrical conductivity, skinfold measurements, and deuterium oxide dilution. Am J Clin Nutr 52: 209-213, 1990.
31. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 72: 6040-6049, 2004.
32. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286: G1032-G1041, 2004.
33. O'Neal WK, Hasty P, McCray PB Jr, Casey B, Rivera-Perez J, Welsh MJ, Beaudet AL, Bradley A. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet 2: 1561-1569, 1993.
34. Peterson ML, Jacobs DR Jr, Milla CE. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics 112: 588-592, 2003.
35. Powers SW, Patton SR, Byars KC, Mitchell MJ, Jelalian E, Mulvihill MM, Hovell MF, Stark LJ. Caloric intake and eating behavior in infants and toddlers with cystic fibrosis. Pediatrics 109: E75, 2002.
36. Rosenberg LA, Schluchter MD, Parlow AF, Drumm ML. Mouse as a model of growth retardation in cystic fibrosis. Pediatr Res 59: 191-195, 2006.
37. Salomonis K, Zambon A, Vranizan K, Lawlaor S, Dahlquist K, Doniger S, Stuart J, Conklin B, Pico A. GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics 8: 217, 2007.
38. Silverman J, Stone DW, Powers JD. The lipid composition of milk from mice fed high or low fat diets. Lab Anim 26: 127-131, 1992.
39. Smith S, Gagne HT, Pitelka DR, Abraham S. The effect of dietary fat on lipogenesis in mammary gland and liver from lactating and virgin mice. Biochem J 115: 807-815, 1969.
40. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal model for cystic fibrosis made by gene targeting. Science 257: 1083-1088, 1992.
41. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 108: 832-839, 2008.
42. Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 124: 244-249, 1994.
43. Stettler N, Kawachak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, Zemel BS. A prospective study of body composition changes in children with cystic fibrosis. Ann NY Acad Sci 904: 406-409, 2000.
44. Stettler N, Kawchak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, Zemel BS. Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. Am J Clin Nutr 72: 407-413, 2000.
45. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23: 3251-3253, 2007.
46. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550, 2005.
47. Towle HC, Kaytor EN, Shih HM. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr 17: 405-433, 1997.
48. Van Ijzendoorn MH, Bakermans-Kranenburg MJ, Juffer F. Plasticity of growth in height, weight, and head circumference: meta-analytic evidence of massive catch-up after international adoption. J Dev Behav Pediatr 28: 334-343, 2007.
49. Wei X, Schneider JG, Shenouda SM, Lee A, Towler DA, Chakravarthy MV, Vita JA, Semenkovich CF. De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J Biol Chem 286: 2933-2945, 2011.
50. Werner A, Bongers ME, Bijvelds MJ, de Jonge HR, Verkade HJ. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. J Lipid Res 45: 2277-2286, 2004.
51. Wouthuyzen-Bakker M, Bijvelds MJ, de Jonge HR, De Lisle RC, Burgerhof JG, Verkade HJ. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Pediatr Res 71: 4-12, 2012.
52. Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McCray PB Jr, Capecchi MR, Welsh MJ, Thomas KR. A mouse model for the F508 allele of cystic fibrosis. J Clin Invest 96: 2051-2064, 1995.
53. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 137: 374-380, 2000.